Stanford University
Showing 29,401-29,450 of 36,204 Results
-
Stephanie Melissa Smith
Assistant Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsI am involved with clinical research related to cancer survivorship, with a particular focus on late effects of childhood cancer treatments and community partnerships to improve health equity for adolescent/young adult cancer survivors in under-resourced settings.
-
Stephen J Smith
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsStephen Smith remains active in the computational microscopy field and is also currently using data science tools to explore new transcriptomic perspectives on signaling by neuropeptides and other neuromodulators in brains of diverse animal species. These exploration have unearthed evidence for a previous unrecognized ubiquity of local neuropeptide signaling and possible critical involvement of such signaling in memory engram formation.
-
Stephen Smith, MD
Clinical Assistant Professor, Ophthalmology
Current Research and Scholarly InterestsRESEARCH OVERVIEW
Dr. Smith’s primary professional interest is developing solutions for unmet clinical and surgical vitreoretinal needs. Beginning in medical school, one of his primary focuses has been improving treatment outcomes in patients with retinoblastoma (RB). During his second year in medical school Dr. Smith published a manuscript on a novel technique to reduce the risk of tumor spread following intravitreal drug delivery in patients with RB. His work summarizing published data on tumor spread following intravitreal injection therapy (IVT) for RB has resulted in multiple platform presentations at national and international meetings, including an invited lecture at ARVO 2014. The results of this study influenced the growing trend toward broader acceptance of intravitreal chemotherapy in pediatric patients with treatment-resistant retinoblastoma vitreous seeds. A primary active area of research has included studying and publishing on ocular toxicity that results from the use of intravitreal melphalan and other agents for RB. This work, and subsequent publications from leaders in the field, has led to an increased awareness of ocular toxicity caused by injecting chemotherapeutic agents into the eyes of young children. This highlighted the need for toxicity data on additional chemotherapeutic agents for local delivery. To answer this question, Dr. Smith assembled an excellent group of collaborators and consultants, including internationally known experts at Bascom Palmer, Mayo Clinic, and Emory University. As a resident he secured a highly competitive career starter grant from the Knights Templar Foundation and used that funding and the expertise of his collaborators to carry out preclinical ocular toxicity studies of combination intravitreal chemotherapy for RB. His work in RB has led to a broader recognition of the challenges facing patients with RB who receive IVT and has led to a continued search for optimal local injectable therapies for patients with this disease.
INNOVATION HIGHLIGHTS
In addition to his work in retinoblastoma, Dr. Smith has been actively involved in developing technologies to improve outcomes for patients receiving intravitreal injection therapy (IVT) for macular degeneration, diabetic retinopathy, retinal vein occlusions and more. IVT has become the most common procedure performed by retina specialists in the United States, with an estimated 6 million injections given in the United States alone in 2016. Dr. Smith has co-developed technology that simplifies and streamlines the IVT process, removing barriers to treatment and improving patient outcomes. His work in innovation covers pre-clinical and clinical development work, and has given him expertise in diverse subject areas including fundraising, intellectual property portfolio development, team building, and business administration. He is a co-founder of iRenix Medical, a biotechnology and medical device start-up company committed to improving vision through optimization of the IVT process.
Dr. Smith remains dedicated to helping improve and restore vision and quality of life in patients with vitreoretinal disease. He is currently involved in both medical device and pharmaceutical innovation, and serves as a mentor for the Stanford University Biodesign Innovation Course. -
Rebecca Smith-Coggins, MD
Professor (Teaching) of Emergency Medicine, Emerita
Current Research and Scholarly InterestsEffect of work schedule on work performance, mood and, sleep architecture in attending emergency medicine physicians,residents.
-
Matthew Smuck, MD
Professor of Orthopaedic Surgery
On Partial Leave from 03/11/2026 To 04/17/2026Current Research and Scholarly InterestsI direct the Wearable Health Lab at Stanford, investigating medical applications of mobile technology to improve musculoskeletal and neurologic disease detection, treatment and prevention.
-
Paul Sniderman
Fairleigh S. Dickinson, Jr. Professor of Public Policy
BioPaul M. Sniderman is the Fairleigh S. Dickinson Jr. Professor in Public Policy.
Sniderman’s research focuses on multiculturalism and politics in Western Europe and spatial reasoning.
He coauthored The Struggle for Inclusion: Muslims and Liberal Democracy (University of Chicago Press, 2020) with Elisabeth Ivarsflaten.
He has published many other books, including When Ways of Life Collide: Multiculturalism and Its Discontents in the Netherlands (Princeton University Press, 2007) with Louk Hagendoorn, Reasoning and Choice, The Scar of Race, Reaching beyond Race, The Outsider, and Black Pride and Black Prejudice, in addition to a plethora of articles. He initiated the use of computer-assisted interviewing to combine randomized experiments and general population survey research.
A fellow of the American Academy of Arts and Sciences and of the American Association for the Advancement of Science, he has been awarded the Woodrow Wilson Prize, 1992; the Franklin L. Burdette Pi Sigma Alpha Award, 1994; an award for the Outstanding Book on the Subject of Human Rights from the Gustavus Meyers Center, 1994; the Gladys M. Kammerer Award, 1998; the Pi Sigma Alpha Award; and the Ralph J. Bunche Award, 2003.
Sniderman received his B.A. degree (philosophy) from the University of Toronto and his M.A. and Ph.D. degrees from the University of California, Berkeley. -
C. Matthew Snipp
Burnet C. and Mildred Finley Wohlford Professor
BioC. Matthew Snipp is the Burnet C. and Mildred Finley Wohlford Professor of Humanities and Sciences in the Department of Sociology at Stanford University. He is also the Director for the Institute for Research in the Social Science’s Secure Data Center and formerly directed Stanford’s Center for the Comparative Study of Race and Ethnicity (CCSRE). Before moving to Stanford in 1996, he was a Professor of Sociology at the University of Wisconsin -- Madison. He has been a Research Fellow at the U.S. Bureau of the Census and a Fellow at the Center for Advanced Study in the Behavioral Sciences. Professor Snipp has published 3 books and over 70 articles and book chapters on demography, economic development, poverty and unemployment. His current research and writing deals with the methodology of racial measurement, changes in the social and economic well-being of American ethnic minorities, and American Indian education. For nearly ten years, he served as an appointed member of the Census Bureau’s Racial and Ethnic Advisory Committee. He also has been involved with several advisory working groups evaluating the 2000 census, three National Academy of Science panels focused on the 2010 and 2020 censuses. He also has served as a member of the Board of Scientific Counselors for the Centers for Disease Control and the National Center for Health Statistics as well as an elected member of the Inter-University Consortium of Political and Social Research’s Council. He is currently serving on the National Institute of Child Health and Development’s Population Science Subcommittee. Snipp holds a Ph.D. in Sociology from the University of Wisconsin—Madison.
-
Blake Marleau Snyder
Clinical Instructor, Ophthalmology
BioBlake Snyder, MD grew up in Colorado and brings his love of skiing, biking, hiking, and live music to a life and career focused on global ophthalmology. He studied biochemistry and chemistry at the University of Colorado, graduating summa cum laude as the only student in his department to do so, with distinction and Phi Beta Kappa honors. He then spent a year as an Intramural Research Training Award Fellow at the National Institutes of Health, where he was first introduced to ophthalmology. During medical school, he was one of six students selected as an AOA Honor Society leader and received both the departmental award in ophthalmology at graduation and a full presidential scholarship. He spent two years completing international ophthalmology research as a Doris Duke/Fogarty Fellow with the Francis I. Proctor Foundation at UCSF, contributing to a project later supported by the Bill & Melinda Gates Foundation. He completed residency at UC Davis, where he served as Chief Resident and co-authored a policy paper that helped advance Congressional legislation on corneal donation access for minority populations. He returned to UCSF and the Proctor Foundation for fellowship training in uveitis and medical cornea and is now a Global Ophthalmology Fellow at Stanford.
